Skip to main content
Premium Trial:

Request an Annual Quote

Richard Begley, Matt Watson, Shiela Robertson

PerkinElmer said this week that Richard Begley has joined the company as vice president and general manager of its Analytical Sciences business. Begley had been president and CEO of Ensemble Discovery. He had the same title at 454 Life Sciences before that and held various positions at Hewlett Packard and its spinoff, Agilent Technologies.
Begley received his PhD in applied physics from StanfordUniversity.

CombiMatrix Molecular Diagnostics this week said it has appointed Mansoor Mohammed CEO of the company, replacing Matt Watson who left to pursue other opportunities. Mansoor was already president of the company as well as its COO.
Watson will remain as a consultant with CombiMatrix for three months, the company said.

Agilent said this week Shiela Robertson will be replacing John Eaton as vice president of corporate development. Eaton will retire on April 30, after 23 years at Agilent and Hewlett Packard.
Robertson will be replaced as operational CFO of the Electronic Measurement Group by Robert Cantrell, who is currently group controller of Agilent’s Global Infrastructure Organization.

Robertson started out as a financial analyst at Hewlett Packard in 1980. She received her bachelor’s degree and MBA from Santa Clara University.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.